VA Tests MDMA-Assisted Therapy for Veterans
Summary
The U.S. Department of Veterans Affairs (VA) has started a clinical trial to test if MDMA-assisted therapy can help veterans with serious mental health problems like PTSD and alcoholism. The study will involve about 80 veterans and compare the effects of MDMA therapy to a placebo, aiming to find better treatments for veterans who do not respond well to current methods.Key Facts
- The VA is conducting a trial to study MDMA-assisted therapy for veterans with severe mental health issues.
- The trial will take place at VA facilities in Rhode Island and Connecticut and will include about 80 veteran participants.
- Some veterans will receive MDMA therapy combined with psychotherapy, while others will get therapy plus a placebo.
- PTSD is a major mental health problem among veterans, especially those who served in combat.
- Current treatments often do not fully help veterans, leading to interest in new approaches like MDMA-assisted therapy.
- MDMA is currently a Schedule I drug in the U.S., meaning it is illegal outside research due to concerns over abuse and lack of accepted medical use.
- The FDA did not approve MDMA therapy for PTSD in 2024, stating more research is needed.
- MDMA-assisted therapy involves a few controlled doses of MDMA combined with multiple therapy sessions, focusing on helping patients open up and process trauma safely.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.